Document Detail

A randomized, double-blind, double-dummy, multicenter, controlled trial on brotizolam intervention in outpatients with insomnia.
MedLine Citation:
PMID:  23025837     Owner:  NLM     Status:  Publisher    
Abstract Aim: To investigate the efficacy and safety of brotizolam in outpatients with insomnia. Methods: This randomized, double-blind, double-dummy, multicenter, controlled trial recruited 253 outpatients randomized to receive either brotizolam (n=126) or estazolam (n=127) for 14 days followed by 1 week of follow-up for rebound detection. Sleep Dysfunction Rating Scale([1]) (SDRS) and Clinical General Impression Scale were applied for efficacy evaluation. Safety evaluation was based on data regarding vital signs, physical examination, lab tests, ECG and collection of adverse events. Results: FAS and SS included data of 251 subjects, with 126 from brotizolam group and 125 from estazolam group. PPS analysis included data of 235 subjects, with 121 and 114 from each group. After 14 days of treatment, there was no difference with statistical significance between the two groups regarding SDRS total score change from baseline. FAS and PPS analysis showed that the brotizolam is non-inferior to estazolam in efficacy evaluation. There was also no difference with statistical significance regarding rebound rate between brotizolam and estazolam group in FAS. The rate of adverse event in two groups was with no statistically significant difference in SS. Conclusion: Brotizolam is effective and safe in relieving the symptoms of insomnia.
Yan Xiaolei; Huang Shuzhen; Ma Cui; Shen Yang; Gu Niufan; Chen Haibo; Wu Wenyuan; Li Shunwei; Hong Zhen; Li Huafang
Related Documents :
24375207 - Noninferiority of perphenazine vs. three second-generation antipsychotics in chronic sc...
24375837 - The effect of perioperative proton pump inhibitors on the incidence of pharyngocutaneou...
24947537 - Economic support to improve tuberculosis treatment outcomes in south africa: a qualitat...
20653747 - The prevalence of depressive symptoms in a white european and south asian population wi...
17198767 - Current guidelines and standards of practice for restless legs syndrome.
12169777 - Cardiac effects of low-dose growth hormone replacement therapy in growth hormone-defici...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-10-1
Journal Detail:
Title:  International journal of psychiatry in clinical practice     Volume:  -     ISSN:  1471-1788     ISO Abbreviation:  Int J Psychiatry Clin Pract     Publication Date:  2012 Oct 
Date Detail:
Created Date:  2012-10-2     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9709509     Medline TA:  Int J Psychiatry Clin Pract     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  SSRIs, adolescents, and aggression: tempering human implications regarding SSRI-induced aggression i...
Next Document:  Early traumatic life events, parental attitudes, family his-tory, and birth risk factors in patients...